Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
N Kader
Observed names:
Kader N,
Nasreen Kader,
Noha Abd El Hafez Abd El Kader
Observed institution:
University of Kirkuk
OpenAlex ID:
A5005002841
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2023
·
O Abani
, A Abbas
, et al.
·
The Lancet Diabetes & Endocrinology
·
41
PDF
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial
2024
·
Saul N Faust
, Richard Haynes
, et al.
·
The Lancet Child & Adolescent Health
·
39
PDF
Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2025
·
O Abani
, A Abbas
, et al.
·
The Lancet Infectious Diseases
·
12
PDF
Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2025
·
O Abani
, A Abbas
, et al.
·
The Lancet Infectious Diseases
PDF
Clinical profile and investigations of acute kidney injury in neonates admitted to NICU.
2024
·
Heba Mustafa Ahmed
, Noha Abd El Hafez Abd El Kader
, et al.
·
International Journal of Applied Biochemistry and Molecular Biology.
Development and Initial Validation of Stigma Towards Healthcare Providers Working with COVID-19 Patients Scale (S19-HCPs)
2021
·
Nashwan AJ
, Al-Fayyadh S
, et al.
·
DOAJ (DOAJ: Directory of Open Access Journals)
Covid_19 and psychosocial effects of salbutamol MDI on repiratory ventilation
2021
·
Nasreen Kader
·
ARID International Journal for Science and Technology
PDF
Show more works
View as search
Works count:
7
Citation count:
92
H-index:
3
I10-index:
3
Year
Topic
Type
